Trials / Completed
CompletedNCT00823745
Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects
A Phase 1 Study To Evaluate The Metabolism And Excretion Of [14C] PF-00868554 In Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1 study to assess the routes of elimination of a single oral dose of \[14C\] PF-00868554 and to characterize the metabolic profile following single dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-PF-00868554 | solution, single dose |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2009-01-16
- Last updated
- 2009-03-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00823745. Inclusion in this directory is not an endorsement.